Effectiveness of Carpal Ligament Self-myofascial Stretching in Carpal Tunnel Syndrome
- Disease/Condition
- Carpal Tunnel Syndrome
- Drug/Device/Intervention
- Carpal ligament self-myofascial stretching
- Study type
- Interventional
- Intervention type
- other
- Primary sponsor
- King Saud University
- Location
- Riyadh, Saudi Arabia
- Phase
- N/A
- Start date
- Nov 17, 2022
- End date
- May 15, 2023
- Enrollment
- 36 participants
Boston Carpal Tunnel Questionnaire,Visual Analogue Scale
Carpal tunnel syndrome (CTS), also known as median mononeuropathy, occurs when the median
 nerve is squeezed or compressed as it travels through the carpal tunnel at the wrist. It is
 common in the age group of 40-60 years. The main aim of the study was to compare the
 effectiveness of carpal ligament self-myofascial stretching over conventional physical
 therapy on reducing pain and improving function in patients with stage I and II
 CTS-thirty-six subjects with stage I and II (mild) CTS were recruited. Thirty-six subjects
 who fulfilled the inclusion criteria were randomly assigned to the experimental group and
 control group, with 18 patients in each group. The experimental group received carpal
 ligament self-myofascial stretching along with conventional physical therapy, while the
 control group received traditional physical therapy alone. The duration of the treatment was
 six weeks. The outcome measures used were the Boston Carpal Tunnel Questionnaire and the
 Visual Analogue Scale.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06229249
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06229249 through Pure Global AI's free database. This phase not specified trial is sponsored by King Saud University and is currently Completed. The study focuses on Carpal Tunnel Syndrome. Target enrollment is 36 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.